If the presence of the original unaltered version of Spry4 in these mesenchymal-derived cell types has had a barely perceptible effect, it is an effective inhibitor of cell proliferation and migration in breast cancer [22] and glioblastoma-derived cells [19]. Here, SPRY4 is linked to breast cancer.